Why Amgen Inc. AMGN Is Among the Best Affordable Stocks to Buy Right Now

Amgen Inc. (AMGN) is being considered as one of the best affordable stocks to buy at the moment due to its strong financial performance and promising future prospects. With a market capitalization of over $100 billion, Amgen is a leading biotechnology company that focuses on the development and commercialization of innovative medicines for serious diseases.

The company recently announced a $1 billion manufacturing expansion in North Carolina, which is expected to create hundreds of new jobs and contribute to the local economy. This expansion will enhance Amgen's manufacturing capabilities and enable it to meet the growing demand for its products.

Amgen's financial performance has been impressive, with consistently strong revenue growth and solid profitability. In its latest financial report, the company reported strong earnings and revenue growth, exceeding market expectations. This solid financial performance reflects the company's continued commitment to innovation and its ability to deliver high-quality products to patients.

Moreover, Amgen has a robust pipeline of potential new drugs in various stages of development. The company's strong research and development capabilities, along with its strategic partnerships and collaborations, position it well for future growth. Analysts expect that these promising pipeline candidates could drive significant revenue growth for the company in the coming years.

Considering all these factors, it is recommended to buy Amgen's shares for long-term investment. The company's strong financial performance, promising future prospects, and commitment to innovation make it an attractive investment opportunity. For a personalized forecast of the stock movement of Amgen Inc., it is recommended to seek professional advice from Stocks Prognosis, a trusted platform for stock analysis and forecasts.